IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 214 filers reported holding IMMUNOGEN INC in Q4 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3 | -99.9% | 631 | 0.0% | 0.00% | – |
| Q3 2022 | $3,000 | +50.0% | 631 | +39.3% | 0.00% | – |
| Q2 2022 | $2,000 | -66.7% | 453 | -68.7% | 0.00% | – |
| Q1 2022 | $6,000 | -33.3% | 1,446 | +15.3% | 0.00% | – |
| Q4 2021 | $9,000 | +350.0% | 1,254 | +151.8% | 0.00% | – |
| Q3 2021 | $2,000 | -50.0% | 498 | -25.2% | 0.00% | – |
| Q2 2021 | $4,000 | -20.0% | 666 | +5.5% | 0.00% | – |
| Q1 2021 | $5,000 | +150.0% | 631 | +66.9% | 0.00% | – |
| Q4 2020 | $2,000 | +100.0% | 378 | -5.3% | 0.00% | – |
| Q3 2020 | $1,000 | -50.0% | 399 | -0.7% | 0.00% | – |
| Q2 2020 | $2,000 | +100.0% | 402 | +1.5% | 0.00% | – |
| Q1 2020 | $1,000 | -75.0% | 396 | -49.3% | 0.00% | – |
| Q4 2019 | $4,000 | +100.0% | 781 | -12.2% | 0.00% | – |
| Q3 2019 | $2,000 | 0.0% | 890 | -10.2% | 0.00% | – |
| Q2 2019 | $2,000 | -87.5% | 991 | -82.9% | 0.00% | – |
| Q1 2019 | $16,000 | – | 5,808 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 10,477,879 | $37,720,000 | 0.69% |
| QVT Financial LP | 1,375,900 | $4,953,000 | 0.60% |
| RA Capital Management | 7,040,485 | $25,346,000 | 0.46% |
| Birchview Capital, LP | 380,000 | $1,368,000 | 0.46% |
| XTX MARKETS LLC | 18,861 | $68,000 | 0.33% |
| Fernwood Investment Management, LLC | 154,340 | $556,000 | 0.26% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $375,000 | 0.14% |
| Virtus ETF Advisers LLC | 70,213 | $253,000 | 0.13% |
| KENNEDY CAPITAL MANAGEMENT LLC | 1,251,458 | $4,505,000 | 0.13% |
| Assenagon Asset Management S.A. | 4,987,334 | $17,954,000 | 0.10% |